investorscraft@gmail.com

Intrinsic value of The Cooper Companies, Inc. (COO)

Previous Close$326.62
Intrinsic Value
Upside potential
Previous Close
$326.62

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh110.11 

The original valuation is based on fiscal year data as of 2021-10-31 and quarterly data as of 2022-07-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %20.2NaN
Revenue, $2923NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m2417NaN
Operating income, $m506NaN
EBITDA, $m847NaN
Interest expense (income), $mNaN
Earnings before tax, $m492NaN
Tax expense, $m-2453NaN
Net income, $m2945NaN

BALANCE SHEET

Cash and short-term investments, $m96NaN
Total assets, $m9606NaN
Adjusted assets (=assets-cash), $m9510NaN
Average production assets, $m5365NaN
Working capital, $m733NaN
Total debt, $m1747NaN
Total liabilities, $m2664NaN
Total equity, $m6942NaN
Debt-to-equity ratio0.252NaN
Adjusted equity ratio0.732NaN

CASH FLOW

Net income, $m2945NaN
Depreciation, amort., depletion, $m341NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m739NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-214NaN
Free cash flow, $m953NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m733
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount